Search research articles
Contact Us
Filters
Showing results (181-190 of 221) with videos related to
Page
of 23
Sort By:
Lupus Science & Medicine
|
June 14, 2022
Impact of low-dose acetylsalicylic acid on pregnancy outcome in systemic lupus erythematosus: results from a multicentre study
Chiara Tani, Dina Zucchi, Isabell Haase, et al.
Frontiers in Immunology
|
November 12, 2020
Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome
Maria Orietta Borghi, Asmaa Beltagy, Emirena Garrafa, et al.
Annals of the Rheumatic Diseases
|
August 1, 2020
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome
Mirko Scarsi, Silvia Piantoni, Enrico Colombo, et al.
Annals of the Rheumatic Diseases
|
May 17, 2019
EULAR recommendations for the management of antiphospholipid syndrome in adults
Maria G Tektonidou, Laura Andreoli, Marteen Limper, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 27, 2020
Anti-phospholipid antibodies in COVID-19 are different from those detectable in the anti-phospholipid syndrome
Maria Orietta Borghi, Asmaa Beltagy, Emirena Garrafa, et al.
Journal of Autoimmunity
|
September 23, 2017
Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study
Luca Iaccarino, Laura Andreoli, Elena Bartoloni Bocci, et al.
Lupus
|
December 17, 2021
COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION)
Xin Wang, Elena Gkrouzman, Danieli Castro Oliveira Andrade, et al.
RMD Open
|
August 8, 2022
Gender equity in academic rheumatology, current status and potential for improvement: a cross-sectional study to inform an EULAR task force
Pavel V Ovseiko, Laure Gossec, Laura Andreoli, et al.
Annals of the Rheumatic Diseases
|
April 26, 2025
EULAR recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation: 2024 update
Linda Rüegg, Andrea Pluma, Sabrina Hamroun, et al.
Arthritis Care & Research
|
September 28, 2020
Characteristics of Patients With Antiphospholipid Antibody Positivity in the APS ACTION International Clinical Database and Repository
Ecem Sevim, Diane Zisa, Danieli Andrade, et al.
Page
of 23
Search research articles
Search
Showing results (181-190 of 221) with videos related to
Sort By:
Page
of 23
Lupus Science & Medicine
|
June 14, 2022
Impact of low-dose acetylsalicylic acid on pregnancy outcome in systemic lupus erythematosus: results from a multicentre study
Chiara Tani, Dina Zucchi, Isabell Haase, et al.
Frontiers in Immunology
|
November 12, 2020
Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome
Maria Orietta Borghi, Asmaa Beltagy, Emirena Garrafa, et al.
Annals of the Rheumatic Diseases
|
August 1, 2020
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome
Mirko Scarsi, Silvia Piantoni, Enrico Colombo, et al.
Annals of the Rheumatic Diseases
|
May 17, 2019
EULAR recommendations for the management of antiphospholipid syndrome in adults
Maria G Tektonidou, Laura Andreoli, Marteen Limper, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 27, 2020
Anti-phospholipid antibodies in COVID-19 are different from those detectable in the anti-phospholipid syndrome
Maria Orietta Borghi, Asmaa Beltagy, Emirena Garrafa, et al.
Journal of Autoimmunity
|
September 23, 2017
Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study
Luca Iaccarino, Laura Andreoli, Elena Bartoloni Bocci, et al.
Lupus
|
December 17, 2021
COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION)
Xin Wang, Elena Gkrouzman, Danieli Castro Oliveira Andrade, et al.
RMD Open
|
August 8, 2022
Gender equity in academic rheumatology, current status and potential for improvement: a cross-sectional study to inform an EULAR task force
Pavel V Ovseiko, Laure Gossec, Laura Andreoli, et al.
Annals of the Rheumatic Diseases
|
April 26, 2025
EULAR recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation: 2024 update
Linda Rüegg, Andrea Pluma, Sabrina Hamroun, et al.
Arthritis Care & Research
|
September 28, 2020
Characteristics of Patients With Antiphospholipid Antibody Positivity in the APS ACTION International Clinical Database and Repository
Ecem Sevim, Diane Zisa, Danieli Andrade, et al.
Page
of 23